- Trials with a EudraCT protocol (4,216)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (372)
Query did not match any clinical trials.
| These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006). | |
| Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records. | |
| Study title: Three-phase radionuclide bone imaging and magnetic resonance imaging detection of occult knee fractures in athletes. Giammarile F, Masciocchi C, Barile A, di Pietro M, Carducci A, Baschieri I. Eur J Nucl Med. 1994 Jun;21(6):493-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43622 |
| Study title: Gips S, Ruchman RB, Groshar D. Bone imaging in Kohler's disease. Clin Nucl Med. 1997 Sep;22(9):636-7. No abstract available. Gips S, Ruchman RB, Groshar D. Bone imaging in Kohler's disease. Clin Nucl Med. 1997 Sep;22(9):636-7. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43543 |
| Study title: Goh AS, Sundram FX, Kumar P. Radionuclide bone imaging in patients with low back pain presenting to the orthopaedic surgeon. Ann Acad Med Singapore. 1986 Oct;15(4):529-34. Goh AS, Sundram FX, Kumar P. Radionuclide bone imaging in patients with low back pain presenting to the orthopaedic surgeon. Ann Acad Med Singapore. 1986 Oct;15(4):529-34. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43892 |
| Study title: Comparative imaging. Septic pulmonary embolus. Sty JR, Lundeen BE, Friedberg DZ. Clin Nucl Med. 1993 Dec;18(12):1090-1. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48270 |
| Study title: Eur J Nucl Med Mol Imaging. 2005 Dec;32(12):1429-39. Epub 2005 Aug 26. Respiration artifacts in whole-body (18)F-FDG PET/CT studies with combined PET/CT tomographs employing spiral CT technology with 1 to 16 detector rows. Beyer T, Rosenbaum S, Veit P, Stattaus J, Müller SP, Difilippo FP, SchÃder H, Mawlawi O, Roberts F, Bockisch A, Kühl H. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28099 |
| Study title: Eur J Nucl Med Mol Imaging. 2005 Jan;32(1):92-7. Epub 2004 Aug 21. Validation of anatomical standardization of FDG PET images of normal brain: comparison of SPM and NEUROSTAT. Hosaka K, Ishii K, Sakamoto S, Sadato N, Fukuda H, Kato T, Sugimura K, Senda M; |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28119 |
| Study title: Eur J Nucl Med Mol Imaging. 2005 Jun;32(6):653-9. Epub 2005 Feb 15. [18F]3'-deoxy-3'-fluorothymidine PET for the diagnosis and grading of brain tumors. Choi SJ, Kim JS, Kim JH, Oh SJ, Lee JG, Kim CJ, Ra YS, Yeo JS, Ryu JS, Moon DH. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28110 |
| Study title: Eur J Nucl Med Mol Imaging. 2005 May;32(5):541-8. Epub 2004 Dec 30. Comment in: Eur J Nucl Med Mol Imaging. 2006 Feb;33(2):228-9; author reply 230. Are dual-phase 18F-FDG PET scans necessary in nasopharyngeal carcinoma to assess the primary tumour and loco-regional nodes? Yen TC, Chang YC, Chan SC, Chang JT, Hsu CH, Lin KJ, Lin WJ, Fu YK, Ng SH. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28115 |
| Study title: Eur J Nucl Med Mol Imaging. 2005 Oct;32(10):1152-9. Epub 2005 Jun 18. Early restaging whole-body (18)F-FDG PET during induction chemotherapy predicts clinical outcome in patients with locoregionally advanced nasopharyngeal carcinoma. Yen RF, Chen TH, Ting LL, Tzen KY, Pan MH, Hong RL. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28101 |
| Study title: Eur J Nucl Med Mol Imaging. 2006 Apr;33(4):428-32. Epub 2006 Jan 11. Prognostic relevance of FDG PET in patients with neurofibromatosis type-1 and malignant peripheral nerve sheath tumours. Brenner W, Friedrich RE, Gawad KA, Hagel C, von Deimling A, de Wit M, Buchert R, Clausen M, Mautner VF. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28091 |
| Study title: Eur J Nucl Med Mol Imaging. 2006 Jan;33(1):13-21. Epub 2005 Sep 9. Diagnostic performance and prognostic impact of FDG-PET in suspected recurrence of surgically treated non-small cell lung cancer. Hellwig D, GrÃschel A, Graeter TP, Hellwig AP, Nestle U, Schäfers HJ, Sybrecht GW, Kirsch CM. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28096 |
| Study title: Eur J Nucl Med Mol Imaging. 2006 Jun;33(6):683-91. Epub 2006 Feb 28. Glut-1 expression and enhanced glucose metabolism are associated with tumour grade in bone and soft tissue sarcomas: a prospective evaluation by [18F]fluorodeoxyglucose positron emission tomography. Tateishi U, Yamaguchi U, Seki K, Terauchi T, Arai Y, Hasegawa T. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28088 |
| Study title: Eur J Nucl Med Mol Imaging. 2006 Jun;33(6):692-6. Epub 2006 Mar 3. Accuracy of transmission CT and FDG-PET in the detection of small pulmonary nodules with integrated PET/CT. Aquino SL, Kuester LB, Muse VV, Halpern EF, Fischman AJ. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28086 |
| Study title: Eur J Nucl Med Mol Imaging. 2006 Sep;33(9):1025-31. Epub 2006 Mar 25. Comparison of 18F-FDG-PET and standard procedures for the pretreatment staging of children and adolescents with Hodgkin's disease. Kabickova E, Sumerauer D, Cumlivska E, Drahokoupilova E, Nekolna M, Chanova M, Hladikova M, Kodet R, Belohlavek O. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28083 |
| Study title: Diaphragmatic hernia producing a perfusion defect and diffuse pulmonary vascular hypoplasia on lung imaging. Siraj QH, Clarke SE. Clin Nucl Med. 1994 Oct;19(10):917-8. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48265 |
| Study title: Esophageal bronchus in an infant diagnosed by fortuitous intubation of the esophagus during ventilation imaging. Kohne RE, McLeary MS, Kirk GA, Young LW. Clin Nucl Med. 1996 Dec;21(12):990-3. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48248 |
| Study title: Esophageal dysmotility as a serendipitous observation on ventilation-perfusion imaging of the lungs. Moallem A, Hilfer C, Stein A. Clin Nucl Med. 1992 Jun;17(6):446-8. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48277 |
| Study title: Acta Neurol Belg. 2001 Dec;101(4):196-209. Guidelines for brain radionuclide imaging. Perfusion single photon computed tomography (SPECT) using Tc-99m radiopharmaceuticals and brain metabolism positron emission tomography (PET) using F-18 fluorodeoxyglucose. The Belgian Society for Nuclear Medicine. Vander Borght T, Laloux P, Maes A, Salmon E, Goethals I, Goldman S; Belgian Society for Nuclear Medicine. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28162 |
| Study title: Ann Acad Med Singapore. 2004 Mar;33(2):183-5. Semi-quantitative measurements of normal organs with variable metabolic activity on FDG PET imaging. Tan LT, Ong KL. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28126 |
| Study title: Carter NJ, Brown A, Barrington SF, O'Doherty MJ, Nunan TO, Coakley AJ. A one-hour walk-in service for wrist trauma imaging. Nucl Med Commun. 1999 Dec;20(12):1161-4. Carter NJ, Brown A, Barrington SF, O'Doherty MJ, Nunan TO, Coakley AJ. A one-hour walk-in service for wrist trauma imaging. Nucl Med Commun. 1999 Dec;20(12):1161-4. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43495 |
| Study title: J Child Neurol. 1994 Apr;9(2):155-61. Neuroimaging in infantile autism. Schifter T, Hoffman JM, Hatten HP Jr, Hanson MW, Coleman RE, DeLong GR. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28204 |
| Study title: J Clin Oncol. 2005 May 1;23(13):3030-7. Increased fluorine-18 2-fluoro-2-deoxy-D-glucose (FDG) uptake in childhood CNS tumors is correlated with malignancy grade: a study with FDG positron emission tomography/magnetic resonance imaging coregistration and image fusion. Borgwardt L, Højgaard L, Carstensen H, Laursen H, Nowak M, Thomsen C, Schmiegelow K. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28104 |
| Study title: Pediatr Radiol. 2004 Mar;34(3):190-8. Epub 2004 Jan 27. PET imaging in pediatric Hodgkin's lymphoma. Hudson MM, Krasin MJ, Kaste SC. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28137 |
| Study title: Q J Nucl Med Mol Imaging. 2006 Mar;50(1):23-7. Cancer screening with FDG-PET. Ide M. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28085 |
| Study title: Q J Nucl Med Mol Imaging. 2006 Mar;50(1):68-77. Clinical impact of fluorine-18 fluorodeoxyglucose positron emission tomography in cancer patients. A comparative study between dedicated camera and dual-head coincidence gamma camera. Andrieux A, Switsers O, Chajari MH, Jacob JH, Delozier T, Gervais R, Allouache N, Laurençon V, Henry-Amar M, Bardet S. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28084 |
| Study title: Radiology. 1998 Oct;209(1):253-8. Combined FDG and [F-18]fluoride whole-body PET: a feasible two-in-one approach to cancer imaging? Hoegerle S, Juengling F, Otte A, Altehoefer C, Moser EA, Nitzsche EU. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28189 |
| Study title: Brill DR. Sports nuclear medicine. Bone imaging for lower extremity pain in athletes. Clin Nucl Med. 1983 Mar;8(3):101-6. Brill DR. Sports nuclear medicine. Bone imaging for lower extremity pain in athletes. Clin Nucl Med. 1983 Mar;8(3):101-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44045 |
| Study title: Brown JN. The suspected scaphoid fracture and isotope bone imaging. Injury. 1995 Sep;26(7):479-82. Brown JN. The suspected scaphoid fracture and isotope bone imaging. Injury. 1995 Sep;26(7):479-82. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43590 |
| Study title: Buck FM, Treumann TC, Winiker H, Strobel K. Chronic recurrent multifocal osteomyelitis (CRMO) with symmetric involvement of both femora: X-ray, bone scintigram, and MR imaging findings in one case. J Magn Reson Imaging. 2007 Aug;26(2):422-6. Buck FM, Treumann TC, Winiker H, Strobel K. Chronic recurrent multifocal osteomyelitis (CRMO) with symmetric involvement of both femora: X-ray, bone scintigram, and MR imaging findings in one case. J Magn Reson Imaging. 2007 Aug;26(2):422-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43363 |
| Study title: Burke TS, Tatum JL, Fratkin MJ, Baker K. Radionuclide bone imaging findings in recurrent calvarial infarction in sickle cell disease. J Nucl Med. 1988 Mar;29(3):411-3. Burke TS, Tatum JL, Fratkin MJ, Baker K. Radionuclide bone imaging findings in recurrent calvarial infarction in sickle cell disease. J Nucl Med. 1988 Mar;29(3):411-3. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43825 |
| Study title: Stereotact Funct Neurosurg. 1995;64 Suppl 1:258-69. Early irradiation effects observed on magnetic resonance imaging and angiography, and positron emission tomography for arteriovenous malformations treated by Gamma Knife radiosurgery. Guo WY, Pan DH, Liu RS, Chung WY, Shiau CY, Cheng SS, Chang CY, Chen KY, Yeh SH, Lee LS. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28200 |
| Study title: Gellad FE, Haney PJ, Sun JC, Robinson WL, Rao KC, Johnston GS. Imaging modalities of craniosynostosis with surgical and pathological correlation. Pediatr Radiol. 1985;15(5):285-90. Gellad FE, Haney PJ, Sun JC, Robinson WL, Rao KC, Johnston GS. Imaging modalities of craniosynostosis with surgical and pathological correlation. Pediatr Radiol. 1985;15(5):285-90. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43962 |
| Study title: Chan WL, Carolan MG, Fernandes VB, Abbati DP. Planar versus SPET imaging in the assessment of condylar growth. Nucl Med Commun. 2000 Mar;21(3):285-90. Chan WL, Carolan MG, Fernandes VB, Abbati DP. Planar versus SPET imaging in the assessment of condylar growth. Nucl Med Commun. 2000 Mar;21(3):285-90. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43484 |
| Study title: Nuclear imaging and clinical features of childhood reflex neurovascular dystrophy: comparison with adults. Goldsmith DP, Vivino FB, Eichenfield AH, Athreya BH, Heyman S. Arthritis Rheum. 1989 Apr;32(4):480-5. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43789 |
| Study title: Biomed Pharmacother. 2006 Nov;60(9):593-606. Epub 2006 Sep 1.18F-FDG PET/CT fusion imaging in paediatric solid extracranial tumours.Nanni C, Rubello D, Castellucci P, Farsad M, Franchi R, Rampin L, Gross MD, Al-Nahhas A, Fanti S. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28075 |
| Study title: Br J Cancer. 2004 Feb 9;90(3):620-5. Substantial impact of FDG PET imaging on the therapy decision in patients with early-stage Hodgkin's lymphoma. Naumann R, Beuthien-Baumann B, Reiss A, Schulze J, Hänel A, Bredow J, Kühnel G, Kropp J, Hänel M, Laniado M, Kotzerke J, Ehninger G. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28136 |
| Study title: Brain Dev. 2001 Dec;23 Suppl 1:S62-71. Neuroimaging studies in Rett syndrome. Naidu S, Kaufmann WE, Abrams MT, Pearlson GD, Lanham DC, Fredericksen KA, Barker PB, Horska A, Golay X, Mori S, Wong DF, Yablonski M, Moser HW, Johnston MV. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28164 |
| Study title: Childs Nerv Syst. 2006 Aug;22(8):810-20. Epub 2006 Jun 24. Functional neuroimaging in the preoperative evaluation of children with drug-resistant epilepsy. Sood S, Chugani HT. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28079 |
| Study title: J Neurosurg. 2006 Feb;104(2):238-53. Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors: a report of 103 consecutive procedures. Pirotte B, Goldman S, Dewitte O, Massager N, Wikler D, Lefranc F, Ben Taib NO, Rorive S, David P, Brotchi J, Levivier M. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28087 |
| Study title: J Nucl Med. 1998 Jul;39(7):1302-5. Procedure guideline for tumor imaging using fluorine-18-FDG. Society of Nuclear Medicine. Schelbert HR, Hoh CK, Royal HD, Brown M, Dahlbom MN, Dehdashti F, Wahl RL. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28191 |
